Corvus Pharmaceuticals stock rebounds on positive trial results
-- Corvus Pharmaceuticals, Inc. (NASDAQ: NASDAQ:CRVS) stock initially tumbled down as much as 18% but then made a remarkable turnaround, trading up 7% following the...
-- Corvus Pharmaceuticals, Inc. (NASDAQ: NASDAQ:CRVS) stock initially tumbled down as much as 18% but then made a remarkable turnaround, trading up 7% following the...
By Nicholas P. Brown and Ananya Mariam Rajesh NEW YORK (Reuters) - Two months into his tenure as Nike (NYSE:NKE) CEO, Elliott Hill gets his first shot on Thursday to convince...
By Jarrett Renshaw and Ernest Scheyder (Reuters) - Advisers to incoming U.S. President Donald Trump are recommending he waive environmental reviews for federally funded critical...
-- The U.S. Department of Justice (DOJ) announced on Wednesday a lawsuit against CVS, accusing the pharmacy giant of filling and billing federal health insurance...
-- Cybersecurity startup Bureau has raised $30 million in a funding round to expand its operations into new markets. The round was led by Sorenson Capital, the firm...
-- Earnings growth driven by AI monetization will be a “key barometer for tech stocks in 2025,” Barclays (LON:BARC) strategists led by Venu Krishna said in a...
-- The U.S. Senate Armed Services Committee has planned a confirmation hearing for Pete Hegseth, the nominee for secretary of defense, on Jan. 14, 2025, according to...
TD Cowen analyst Roman Schweizer highlighted that Congress agreed to a Continuing Resolution (CR) that will fund the U.S. government through March 14, 2024, and includes $100...
-- Shares of pharmaceutical giant Merck & Co ., Inc. (NYSE:MRK) edged up 1.6% in premarket trading following news of a significant licensing agreement with Chinese...
-- Shares of Dow Inc (NYSE:DOW). rose on Wednesday during pre-market trading following an upgrade from analysts at Evercore ISI. The brokerage shifted its rating on...